BOC Sciences - Products
London
BOC Sciences provides various research (bio)chemicals: inhibitors, building blocks, carbohydrates, nucleosides, nucleotides, GMP Products, impurities, metabolites, APIs, natural compounds, ADCs, and chiral compounds.
| Product | Description | |
|---|---|---|
| GSK-461364 | GSK-461364 is a Polo-like kinase 1 inhibitor, is also a small molecule Polo-like kinase 1 (PLK1) inhibitor with potential antineoplastic activity. Polo-like kinase 1 inhibitor GSK461364 selectively inhibits Plk1, inducing selective G2/M arrest followed by apoptosis in a variety of tumor cells while causing reversible cell arrest at the G1 and G2 stage without apoptosis in normal cells. Plk1, named after the polo gene of Drosophila melanogaster, is a serine/threonine protein kinase involved in regulating mitotic spindle function in a non-ATP competitive manner. Group: Pharmaceutical. CAS No. 929095-18-1. Pack Sizes: 10 mg. Product ID: B0084-307746. Molecular formula: Custom synthesis is available. Send your inquiries for more information. |  London |
| GSK525762 | GSK525762A, also known as I-BET-762 and GSK525762, is a small molecule inhibitor of the BET (Bromodomain and Extra-Terminal) family of bromodomain-containing proteins with potential antineoplastic activity. Upon administration, the BET inhibitor GSK525762 binds to the acetylated lysine recognition motifs on the bromodomain of BET proteins, thereby preventing the interaction between the BET proteins and acetylated histone peptides. This disrupts chromatin remodeling and gene expression. Prevention of the expression of certain growth-promoting genes may lead to an inhibition of tumor cell growth. Characterized by a tandem repeat of bromodomain at the N-terminus, BET proteins, comprising of BRD2, BRD3, BRD4 and BRDT, are transcriptional regulators that play an important role during development and cellular growth. Group: Pharmaceutical. CAS No. 1260907-17-2. Pack Sizes: 25 mg. Product ID: B2693-457801. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| GSK547 | GSK547 is a highly selective and potent RIP1 (RIPK1) inhibitor which displays 400-fold improvement in mouse pharmacokinetic oral exposure compared with GSK963. Group: Pharmaceutical. CAS No. 2226735-55-1. Pack Sizes: 10 mg. Product ID: B2693-334088. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| GSK583 | GSK583 is a selective receptor-interacting serine/threonine-protein kinase 2 (RIP2 Kinase) inhibitor and the RIP2K binding IC50 is 5 nM. GSK583 can inhibit both TNF-α and IL-6 production with an IC50 value of 200 nM in an ex vivo human translational model. Group: Pharmaceutical. CAS No. 1346547-00-9. Pack Sizes: 25 mg. Product ID: B0084-475334. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| GSK-7975A | This active molecular is a calcium release-activated calcium modulator (ORAI1) inhibitor. GSK-7975A inhibited toxin-induced activation of ORAI1 and/or activation of Ca(2+) currents after Ca(2+) release in mouse and human pancreatic acinar cells. GSK-7975A may be used for the treatment of pancreatitis in the future. Uses: Pancreatitis. Group: Pharmaceutical. CAS No. 1253186-56-9. Pack Sizes: 50 mg. Product ID: B0084-475226. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| GSK-8573 | GSK-8573 is an inactive control of GSK-2801, which is a potent inhibitor of BAZ2A and BAZ2B bromodomains. Group: Pharmaceutical. CAS No. 1693766-04-9. Pack Sizes: 50 mg. Product ID: B0084-284771. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| GSK-923295 | GSK-923295 is a novel antimitotic inhibitor of centromere-associated protein E (CENP-E) with potential anticancer activity. GSK-923295 demonstrated significant antitumor activity against solid tumor models, inducing CRs in Ewing sarcoma, rhabdoid, and rhabdomyosarcoma xenografts. Clinical study showed that GSK-923295 had dose-proportional pharmacokinetics and a low number of grade 3 or 4 adverse events. The observed incidence of myelosuppression and neuropathy was low. Further investigations may provide a more complete understanding of the potential for GSK-923295 as an antiproliferative agent. Group: Pharmaceutical. CAS No. 1088965-37-0. Pack Sizes: 100 mg. Product ID: B1370-456847. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| GSK-LSD1 2HCl | GSK-LSD1 2HCl is an irreversible, and selective LSD1 inhibitor with IC50 of 16 nM, > 1000 fold selective over other closely related FAD utilizing enzymes (i.e. LSD2, MAO-A, MAO-B). Group: Pharmaceutical. CAS No. 1431368-48-7. Pack Sizes: 50 mg. Product ID: B2693-463426. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| GsMTx4 | GsMTx4 is a mechanosensitive and stretch-activated ion channel inhibitor. It is used as a tool for identifying the role of these excitatory MSCs in normal physiology and pathology. Group: Pharmaceutical. CAS No. 1209500-46-8. Pack Sizes: 1 mg. Product ID: BAT-006147. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| GsMTx4 TFA | GsMTx4 is a TRPC1 and TRPC6 blocker, and also blocks stretch-activated cation channels in astrocytes, cardiac cells, and skeletal muscle cells. Group: Pharmaceutical. Pack Sizes: 5 mg. Product ID: BAT-016122. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| GTS-21 dihydrochloride | GTS-21, also known as DMBX-A, is a derivative of the natural product anabaseine that acts as a partial agonist at neural nicotinic acetylcholine receptors. It binds to both the α4β2 and α7 subtypes, but activates only the α7 to any significant extent. Group: Pharmaceutical. CAS No. 156223-05-1. Pack Sizes: 100 mg. Product ID: B0084-436419. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Guaiacin | Guaiacin is a lignan isolated from the leaves of Guaiacum officinale. Guaiacin inhibits COX-1 and COX-2 leading to the reduction of inflammations. Group: Pharmaceutical. CAS No. 36531-08-5. Pack Sizes: 5 mg. Product ID: B0005-053620. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Guaifenesin Impurities | Guaifenesin Impurities are chemical by-products found in the synthesis of Guaifenesin, an expectorant used to treat respiratory conditions such as colds, bronchitis, and other respiratory tract infections. Identifying and controlling these impurities is crucial for ensuring the drugs safety, efficacy, and quality standards in pharmaceutical formulations. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Guaijaverin | Guaijaverin is a natural flavonoid found in the fruits of Psidium guajava Linn. Guaijaverin exhibits antioxidant activity and antibacterial activity against Strep. mutans. And guaijaverin is a good inhibitor for urease. Group: Pharmaceutical. CAS No. 22255-13-6. Pack Sizes: 100 mg. Product ID: NP1872. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Guajadial B | Guajadial B isolated from the herbs of Psidium guajava. Group: Pharmaceutical. CAS No. 1414455-03-0. Pack Sizes: 1 mg. Product ID: NP5650. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Guajadial D | Guajadial D is a sesquiterpenoid-based meroterpenoid isolated from the leaves of Psidium guajava. Guajadial D has potential anticancer effects. Group: Pharmaceutical. CAS No. 1529775-04-9. Pack Sizes: 1 mg. Product ID: NP5962. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Guajadial E | Guajadial E is a sesquiterpenoid-based meroterpenoid isolated from the leaves of Psidium guajava. Guajadial E has potential anticancer effects. Group: Pharmaceutical. CAS No. 1529775-06-1. Pack Sizes: 1 mg. Product ID: NP5876. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Guajadial F | Guajadial F is a sesquiterpenoid-based meroterpenoid isolated from the leaves of Psidium guajava. Guajadial F has potential anticancer effects. Biochemical topoisomerase I (Top1) assay revealed that guajadial F acted as a Top1 catalytic inhibitor and delayed Top1 poison-mediated DNA damage. Group: Pharmaceutical. CAS No. 1529775-08-3. Pack Sizes: 1 mg. Product ID: NP5861. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Guanfacine hydrochloride | Guanfacine, a selective agonist of α2A receptor, is a sympatholytic drug to treat attention deficit hyperactivity disorder (ADHD) and hypertension. It lowers both systolic and diastolic blood pressure. Group: Pharmaceutical. CAS No. 29110-48-3. Pack Sizes: 500 mg. Product ID: B0084-065259. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Guanfacine Impurities | Guanfacine Impurities play a critical role in the biomedical industry, primarily utilized in the quality control and stability analysis of Guanfacine-based medications. These impurities are essential in ensuring drug purity and safety, aiding in the effective treatment of conditions such as attention deficit hyperactivity disorder (ADHD) and hypertension. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Guanine Impurities | Guanine Impurities, byproducts in guanine synthesis, are pivotal in the pharmaceutical sector for their role in ensuring drug purity. They are extensively analyzed in treatments for viral infections like HIV and chronic ailments such as gout, where ensuring the pristine quality of guanine derivatives is crucial for therapeutic efficacy. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Guanosine 5'-diphosphate disodium salt | Guanosine 5'-diphosphate disodium salt is an imperative biomolecule esteemed in the biomedical sector, exhibiting noteworthy involvement in cellular signaling and serves as a substrate for diverse nucleic acid metabolism-encompassing enzymes. Its significance is exemplified through extensive employment in research and manufacturing, enabling comprehensive exploration of G-protein coupled receptors, protein synthesis and drug discovery-related signaling pathways, as well as disease research. Group: Pharmaceutical. CAS No. 7415-69-2. Pack Sizes: 10 g. Product ID: B2001-013437. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Guanosine 5-monophosphomorpholidate | Guanosine 5-monophosphomorpholidate - an invaluable biomedical product - finds its application in the treatment of various diseases. As a precursor for synthesizing targeted drugs against viral infections and cancerous cells, it showcases its remarkable potential. Notably, this compound plays a pivotal role in signaling pathways, guiding and governing vital cellular processes concerning DNA synthesis and repair. Its multifaceted involvement in these intricate mechanisms underscores its significance in the realm of biomedical sciences. Group: Pharmaceutical. CAS No. 7361-7-1. Pack Sizes: 10 g. Product ID: B2706-301736. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Guanosine-5'-triphosphate trisodium salt | Guanosine-5'-triphosphate sodium salt could be used as a phosphoryl donor in signal transduction and protein synthesis. Group: Pharmaceutical. CAS No. 36051-31-7. Pack Sizes: 500 mg. Product ID: B2001-005564. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| GW0742 | GW0742 is a potent and highly selective PPARβ/δ agonist, with IC50 of 1 nM, with 1000-fold selectivity over hPPARα and hPPAR&gamma. Group: Pharmaceutical. CAS No. 317318-84-6. Pack Sizes: 50 mg. Product ID: B0084-178999. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| GW1929 | A potent, tyrosine-based peroxisome proliferator-activated receptor γ (PPARγ) agonist (EC50 = 13 nM for murine receptor and 6.2 nM for human receptor in cell-based transactivation assays). Group: Pharmaceutical. CAS No. 196808-24-9. Pack Sizes: 50 mg. Product ID: B2693-196515. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| GW3965 Hydrochloride | GW3965 HCl is a potent, selective LXR agonist for hLXRα and hLXRβ with EC50 of 190 and 30 nM, respectively. Group: Pharmaceutical. CAS No. 405911-17-3. Pack Sizes: 100 mg. Product ID: B0084-372170. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| GW 441756 | GW 441756 is a potent and selective Tropomyosin-related kinase A (TrkA) inhibitor (IC50 = 2 nM), reducing cell proliferation and potentiates the effects of chemotherapeutic agents. Uses: A specific tropomyosin-related kinase a (trka) inhibitor. Group: Pharmaceutical. CAS No. 504433-23-2. Pack Sizes: 50 mg. Product ID: B0084-093225. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| GW4869 | GW4869 is a cell-permeable, specific and non-competitive inhibitor of neutral sphingomyelinases (IC50 = 1 μM). Group: Pharmaceutical. CAS No. 6823-69-4. Pack Sizes: 10 mg. Product ID: B0084-301751. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| GW 627368X | GW 627368X is a potent and selective competitive antagonist of the EP4 receptor with additional human TP receptor affinity (Ki values of 100 nM and 158 nM, respectively). Uses: A potent and selective competitive antagonist. Group: Pharmaceutical. CAS No. 439288-66-1. Pack Sizes: 50 mg. Product ID: B0084-313850. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| GW-870086 | GW-870086 is a glucocorticoid receptor agonist with a pIC50 of 10.1 in A549 cells expressing NF-κB. It can be used as an anti-inflammatory agent. Group: Pharmaceutical. CAS No. 827319-43-7. Pack Sizes: 50 mg. Product ID: B0084-260284. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| GW9508 | GW9508 is a potent and selective agonist for FFA1 (GPR40) with pEC50 of 7.32, 100-fold selective against GPR120, and stimulates insulin secretion in a glucose-sensitive manner. GW9508 is commonly used in the treatment of type 2 diabetes. Group: Pharmaceutical. CAS No. 885101-89-3. Pack Sizes: 100 mg. Product ID: B0084-272136. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| GX-674 | GX-674 is a Nav1.7 antagonist in the aryl sulfonamide class with higher selectivity for Nav1.7 (IC50= 0.1nM) over other Nav subtypes. Nav1.7 is commonly expressed in olfactory epithelium, sympathetic ganglion, and dorsal root ganglion sensory neurons. GX-674 has the potential to alleviate extreme pains. Group: Pharmaceutical. CAS No. 1432913-36-4. Pack Sizes: 5 mg. Product ID: B2693-074250. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Gymnestrogenin | Gymnestrogenin is a triterpenoid compound found in the Gymnema sylvestre. with dual LXRα/β antagonistic property. Group: Pharmaceutical. CAS No. 19942-02-0. Pack Sizes: 5 mg. Product ID: B0005-053603. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Gypenoside XLVI | Gypenosides are triterpenoid saponins isolated from Gynostemma pentaphyllum. Group: Pharmaceutical. CAS No. 94705-70-1. Pack Sizes: 10 mg. Product ID: B2703-003139. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Gyrophoric acid | Gyrophoric acid isolated from the herbs of Parmelia tinctorum Despr. Uses: Anti-tumor; anti-cancer; antibacterial; antimicrobial; anti-proliferative/cytotoxic effect. Group: Pharmaceutical. CAS No. 548-89-0. Pack Sizes: 1 mg. Product ID: NP5028. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| GYY-4137 Morpholine salt | GYY-4137 Morpholine salt is a novel water-soluble and slow releasing Hydrogen sulfide(H2S) donor. It protects against myocardial ischemia and reperfusion injury by attenuating oxidative stress and apoptosis in rats. It inhibits the inflammatory response by suppressing the activation of nuclear factor-kappa B and mitogen-activated protein kinases in Coxsackie virus B3-infected rat cardiomyocytes. It exhibits potent anti-cancer activity. It exhibits vasodilator and antihypertensive activity in rats, in either the acute or chronic hypertension models. It does not influence vascular smooth muscle cell viability in culture. It also protects against endotoxic shock in rats, inhibiting tumor necrosis factor-α, interleukin (IL)-1β, and IL-6 production and reducing NF-κB activation, iNOS and cyclooxygenase-2 expression, and NO and prostaglandin E2 generation. Uses: Gyy-4137 morpholine salt inhibits the inflammatory response. it exhibits potent anti-cancer activity. it exhibits vasodilator and antihypertensive activity. Group: Pharmaceutical. CAS No. 106740-09-4. Pack Sizes: 100 mg. Product ID: B2693-272139. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| H3B-6527 | H3B-6527 is a potent, highly selective and orally active FGFR4 inhibitor with potential antineoplastic activity. Group: Pharmaceutical. CAS No. 1702259-66-2. Pack Sizes: 10 mg. Product ID: B0084-482212. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| H 89 2HCl | H 89 2HCl is a cell permeable and potent PKA inhibitor with Ki of 48 nM in a cell-free assay, wihich is 10-fold selective for PKA than PKG, 500-fold greater selectivity than PKC, MLCK, calmodulin kinase II and casein kinase I/II. Group: Pharmaceutical. CAS No. 130964-39-5. Pack Sizes: 100 mg. Product ID: B0084-360949. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Haginin A | Haginin A is a natural compound isolated from the aerial parts of Lespedeza cyrtobotrya. Haginin A has radical scavenging activity and mushroom tyrosinase inhibitory activity. Haginin A is an effective inhibitor of hyperpigmentation caused by UV irradiation or by pigmented skin disorders through downregulation via ERK and Akt/PKB activation, MITF, and also by the subsequent downregulation of tyrosinase and TRP-1 production. Group: Pharmaceutical. CAS No. 74174-29-1. Pack Sizes: 5 mg. Product ID: NP2192. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Halobetasol Impurities | Halobetasol Impurities represent an essential facet in the analytical evaluation process, crucial for determining the purity and quality of Halobetasol, a highly effective topical corticosteroid for inflammatory dermatological conditions such as psoriasis and eczema. These impurities demand precise identification and quantification to uphold the therapeutic formulation's safety and efficacy standards. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Halofuginone | Halofuginone is a semisynthetic quinazolinone alkaloid anticoccidial derived from the plant Dichroa febrifuga, with antifibrotic and potential antineoplastic activities. Halofuginone specifically inhibits collagen type I gene expression and matrix metalloproteinase 2 (MMP-2) gene expression, which may result in the suppression of angiogenesis, tumor stromal cell development, and tumor cell growth. These effects appear to be due to halofuginone-mediated inhibition of the collagen type I and MMP-2 promoters. Collagen type I and MMP-2 play important roles in fibro-proliferative diseases. Uses: Semisynthetic quinazolinone alkaloid anticoccidial. Group: Pharmaceutical. CAS No. 55837-20-2. Pack Sizes: 100 mg. Product ID: B0084-071625. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Halofuginone hydrobromide | Halofuginone hydrobromide is a salt form of Halofuginone, which is a coccidiostat used in veterinary medicine. Group: Pharmaceutical. CAS No. 64924-67-0. Pack Sizes: 1 g. Product ID: B2692-074439. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Halofuginone Impurities | Halofuginone Impurities are integral in the biomedical sector for quality control during the synthesis of halofuginone, an antifibrotic and antimalarial agent. By ensuring the purity and efficacy of halofuginone, these impurities play a crucial role in the ongoing research and development of treatments for fibrotic diseases and malaria. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Halofuginone lactate | Halofuginone lactate is a halogenated derivative of febrifugine. Halofuginone inhibits prolyl-tRNA synthetase in an ATP-dependent manner with a Ki of 18.3 nM. Group: Pharmaceutical. CAS No. 82186-71-8. Pack Sizes: 250 mg. Product ID: B2692-136247. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Halometasone Impurities | Halometasone Impurities are pivotal in quality control during the synthesis of halometasone, a corticosteroid used to manage inflammatory skin disorders like eczema and psoriasis. These impurities provide crucial insights into the pharmacological and safety profiles of halometasone, ensuring its therapeutic efficacy and compliance with pharmaceutical standards. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Hard Fat | Hard Fat is a common ingredient found in many cosmetic and personal care products, such as lotions, creams, and makeup. Group: Pharmaceutical. CAS No. 91744-42-2. Pack Sizes: 1 kg. Product ID: B1370-286568. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Hardwickiic acid | Hardwickiic acid is isolated from the herbs of Hardwickia pinnata. Group: Pharmaceutical. CAS No. 1782-65-6. Pack Sizes: 1 mg. Product ID: NP1380. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Harpagoside | Harpagoside, isolated from the Harpagophytum procumbens (Devil's Claw) root or Crophularia ningpoensis Hemsl (Figwort), inhibited lipopolysaccharide-induced mRNA levels. Harpagoside also inhibited protein expression of cyclooxygenase-2 and inducible nitric oxide in HepG2 cells, which involves suppression of NF-kappaB activation, thereby inhibiting downstream inflammation and subsequent pain events. Uses: Anti-inflammatory. Group: Pharmaceutical. CAS No. 19210-12-9. Pack Sizes: 50 mg. Product ID: NP3892. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Hautriwaic acid | Hautriwaic acid is a natural diterpenoid found in the herbs of Dodonaea viscosa. Hautriwaic acid may have hepatoprotective activity. Uses: Hepatoprotective. Group: Pharmaceutical. CAS No. 18411-75-1. Pack Sizes: 5 mg. Product ID: NP1276. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| HC-030031 | HC-030031 is a selective TRPA1 channel blocker that antagonizes AITC- and formalin-evoked calcium influx with IC50 of 6.2 μM and 5.3 μM respectively. Group: Pharmaceutical. CAS No. 349085-38-7. Pack Sizes: 1 g. Product ID: B2693-370807. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| H-D-3-Pal-OH 2HCl | H-D-3-Pal-OH 2HCl, a synthetic peptide of scientific interest, has the potential to be a promising avenue in the pursuit of new treatments for diseases of varying kinds. Research into the properties of this compound suggests its ability to inhibit cell proliferation and promote apoptosis in oncogenic cells. Interestingly, it may also function as an immunomodulator and possess therapeutic applications towards autoimmune disorders. These findings speak to the complex and multifaceted nature of H-D-3-Pal-OH 2HCl and the implications it could have in furthering scientific understanding of these conditions. Group: Pharmaceutical. CAS No. 93960-21-5. Pack Sizes: 1 g. Product ID: BAT-004823. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| H-D-allo-Threonine Methyl Ester Hydrochloride | H-D-allo-Threonine Methyl Ester Hydrochloride is used to prepare hepatitis A virus 3C cysteine protease inhibitors. Group: Pharmaceutical. CAS No. 60538-18-3. Pack Sizes: 1 g. Product ID: B2699-039416. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| H-D-Leu-Thr-Arg-PNA | H-D-Leu-Thr-Arg-PNA. Group: Pharmaceutical. CAS No. 122630-72-2. Pack Sizes: 10 mg. Product ID: BAT-006240. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Hebeirubescensin H | Hebeirubescensin H is a natural diterpenoid compound found in several plants. Group: Pharmaceutical. CAS No. 887333-30-4. Pack Sizes: 1 mg. Product ID: NP1223. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Hederacolchiside A1 | Hederacolchiside A1, an awe-inspiring compound derived from the natural reserves of Pulsatilla chinensis. Graced with the remarkable ability to instigate programmed cellular death and differentiation, it serves as a beacon of hope in the realm of acute promyelocytic leukemia therapy. Group: Pharmaceutical. CAS No. 106577-39-3. Pack Sizes: 5 mg. Product ID: NP7227. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Hederacolchiside E | Hederacolchiside E is extracted from Pulsatilla chinensis (Bunge) Regel. Group: Pharmaceutical. CAS No. 33783-82-3. Pack Sizes: 5 mg. Product ID: B0005-465769. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Hederacoside C | Hederacoside C is one of the active ingredients in Hedera helix leaf extract. Group: Pharmaceutical. CAS No. 14216-03-6. Pack Sizes: 20 mg. Product ID: NP7027. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Hederagenin - 3-O-β-D- Galactosyl( 1?3)-β-D-glucosyl( 1?3)-α-L-rhamnosyl(1?2)-α-L-arabinoside | Hederagenin - 3-O-β-D- Galactosyl( 1→3)-β-D-glucosyl( 1→3)-α-L-rhamnosyl(1→2)-α-L-arabinoside is a triterpenoids isolated from pulsatilla chinensis BungeRegel. Pulsatilla chinensis (Bunge) Regel is a botanical with a long history of medical use in China, which exhibits "blood-cooling" and detoxification activities. The roots of P. chinensis have been widely used in the traditional Chinese medicine for adjunctive treatment of intestinal amebiasis, malaria, vaginal trichomoniasis, bacterial infections and malignant tumor. Group: Pharmaceutical. Pack Sizes: 10 mg. Product ID: B0005-482208. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Hederagonic acid | Hederagonic acid is a natural triterpenoid found in the root of Pulsatilla chinensis. Group: Pharmaceutical. CAS No. 466-01-3. Pack Sizes: 1 mg. Product ID: NP6866. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Hedycoronen A | Hedycoronen A is an inhibitor of LPS-stimulated interleukin-6 (IL-6) and IL-12 p40, exhibiting potential anti-inflammatory activity. Group: Pharmaceutical. CAS No. 1383441-73-3. Pack Sizes: 1 mg. Product ID: NP1260. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Helichrysetin | Helichrysetin is a natural chalcone isolated from the fruits of Alpinia katsumadai Hayata, it exhibits the activity of anticancer and has mild anti-HIV-1 PR activity. Uses: Anticancer. Group: Pharmaceutical. CAS No. 62014-87-3. Pack Sizes: 1 mg. Product ID: NP0938. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Hellebrigenin | Hellebrigenin is an anticancer agent that induces DNA damage, mitochondria collapse, cell cycle arrest and apoptosis. Group: Pharmaceutical. CAS No. 465-90-7. Pack Sizes: 5 mg. Product ID: B0084-134330. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Heparan Sulfate | Heparan sulfate, a complex and linear polysaccharide in which the backbone is composed of repeating sulfated disaccharide units, exists as part of glycoproteins named heparan sulfate proteoglycans, which are expressed abundantly on the cell surface and in the extracellular matrix. Group: Pharmaceutical. CAS No. 9050-30-0. Pack Sizes: 5 mg. Product ID: B2693-448115. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Heparin disaccharide I-S, tetrasodium salt | It is a predominant disaccharide produced from heparin by heparinase I and II. Group: Pharmaceutical. CAS No. 136098-10-7. Pack Sizes: 1 mg. Product ID: B2705-231865. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Heparin Impurities | Heparin Impurities are detected and studied as part of pharmaceutical quality control, particularly in anticoagulant therapies. Understanding these impurities aids in ensuring the safety and efficacy of heparin, used widely to prevent and treat thromboembolic disorders, including deep vein thrombosis and pulmonary embolism. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Heparin Sodium | Heparin sodium is a sodium salt of heparin which is a naturally-occurring anticoagulant used for anticoagulation for cardiovascular disease. It is an inhibitor of activated coagulation factors such as Factors Xa and IIa (thrombin). Uses: Anticoagulation for cardiovascular disease. Group: Pharmaceutical. CAS No. 9041-8-1. Pack Sizes: 10 g. Product ID: B0084-325124. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Heparosan from E. coli K5 | Heparosan is an endogenous Glycosaminoglycan biosynthesized and secreted by E. coli K5. Heparosan serves as the starting carbon backbone for the chemoenzymatic synthesis of heparin, a widely used clinical anticoagulant drug. Group: Pharmaceutical. Pack Sizes: 1 g. Product ID: B1370-285296. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Heptadecanedioic acid | Heptadecanedioic acid (CAS# 2424-90-0 ) is a useful research chemical. Group: Pharmaceutical. CAS No. 2424-90-0. Pack Sizes: 1 g. Product ID: B0001-195231. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Heptakis(6-deoxy-6-thio)-beta-cyclodextrin | Heptakis(6-deoxy-6-thio)-beta-cyclodextrin is a vital compound extensively used in the biomedical industry. With its exceptional binding capabilities, it is commonly employed in drug formulation and delivery systems. This product plays a significant role in enhancing the solubility and stability of various drugs, allowing for improved therapeutic outcomes. Group: Pharmaceutical. CAS No. 160661-60-9. Pack Sizes: 500 mg. Product ID: B2705-286507. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
Would you like to list your products on UK Chemical Suppliers?
Our database is helping our users find suppliers everyday.